Duracin y paciencia: Los efectos del GHK-Cu no son inmediatos
Only ShHTL1, in the conserved clade, was capable of binding KAR 1 (dissociation constant ( K D ): 77 12 M
Future studies are needed to elucidate the immunologic synergism between ICIs and concomitant medications in order to optimize clinical management and risk prediction
As we cannot evaluate what we do not measure, quantitative assessment of the therapeutic benefits of Al-hijamah should be performed
EAAT2, Excitatory amino acid transporter 2
Int Arch Otorhinolaryngol 26(01):167177 Ferreira-Cendon S, Martinez-Carranza R, Fernandez-Nava MJ, Villaoslada-Fuente R, Sanchez-Gomez H, Santa Cruz-Ruiz S, Sanchez-Ledesma M, Batuecas-Caletrio A (2022) Prevention of severe vestibular hypofunction after systemic gentamicin